文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气患者气道铜绿假单胞菌密度:临床影响与抗生素疗效的关系

Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics.
PubMed 文献 · Crit Care · 2021-02-11
一句话结论高铜绿假单胞菌密度(≥10^7 cfu/mL)与更少无呼吸机天数和更高ICU死亡率独立相关,仅在密度高时抗生素治疗与改善脱机相关。

该回顾性研究纳入461例机械通气ICU患者,按气道铜绿假单胞菌峰值密度分为低(≤10^4 cfu/mL)、中(10^5‒10^6 cfu/mL)、高(≥10^7 cfu/mL)三组。高密度组炎症指标更高、呼吸道感染更重,且与28天无呼吸机天数减少(P<0.01)和ICU死亡率增加(P=0.047)独立相关。高密度风险因素包括延长机械通气、使用非抗假单胞菌头孢菌素、高血糖和呼吸系统疾病。倾向评分匹配分析显示,仅在高峰值密度组中,抗生素治疗与呼吸机相关性气管支气管炎患者脱机改善相关。

要点

  • 高铜绿假单胞菌峰值密度(≥10^7 cfu/mL)独立关联28天无呼吸机天数减少(P<0.01)和ICU死亡率增加(P=0.047)。
  • 高密度风险因素:延长机械通气(OR 3.07, 95%CI 1.35‒6.97)、非抗假单胞菌头孢菌素(OR 2.17, 95%CI 1.35‒3.49)、高血糖(OR 2.01, 95%CI 1.26‒3.22)、呼吸系统疾病(OR 1.9, 95%CI 1.12‒3.23)。
  • 分离出共生定植菌与高峰值密度风险降低相关(OR 0.43, 95%CI 0.26‒0.73)。
  • 倾向评分匹配分析显示,抗生素治疗仅在高密度组与呼吸机相关性气管支气管炎患者脱机改善相关。
  • 细菌密度可能作为铜绿假单胞菌所致呼吸机相关性气管支气管炎的疗效指标。

适用人群与场景

  • 机械通气ICU患者,气管内吸出物分离出铜绿假单胞菌。

诊断标准与关键阈值

  • 按ICU期间铜绿假单胞菌峰值密度分组:低密度组≤10^4 cfu/mL,中密度组10^5‒10^6 cfu/mL,高密度组≥10^7 cfu/mL。

研究设计与关键结果

  • 回顾性分析461例机械通气ICU患者,按铜绿假单胞菌峰值密度分为低、中、高三组。
  • 高密度组患者炎症指标更高,呼吸道感染更严重。
  • 高密度独立关联28天无呼吸机天数减少(P<0.01)和ICU死亡率增加(P=0.047)。
  • 高密度风险因素:延长机械通气(OR 3.07, 95%CI 1.35‒6.97)、非抗假单胞菌头孢菌素(OR 2.17, 95%CI 1.35‒3.49)、高血糖(OR 2.01, 95%CI 1.26‒3.22)、呼吸系统疾病(OR 1.9, 95%CI 1.12‒3.23)。
  • 分离出共生定植菌与高密度风险降低相关(OR 0.43, 95%CI 0.26‒0.73)。
  • 倾向评分匹配分析显示,抗生素治疗仅在高密度组与呼吸机相关性气管支气管炎患者脱机改善相关。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于机械通气患者,若气道铜绿假单胞菌峰值密度≥10^7 cfu/mL,提示预后较差(无呼吸机天数减少、ICU死亡率增加)。
  • 在呼吸机相关性气管支气管炎患者中,抗生素治疗仅在高密度组与脱机改善相关,细菌密度可能作为治疗指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The bacterial density of Pseudomonas aeruginosa is closely related to its pathogenicity. We evaluated the effect of airway P. aeruginosa density on the clinical course of mechanically ventilated patients and the therapeutic efficacy of antibiotics.

METHODS: We retrospectively analyzed data of mechanically ventilated ICU patients with P. aeruginosa isolated from endotracheal aspirates. Patients were divided into three groups according to the peak P. aeruginosa density during ICU stay: low (≤ 104 cfu/mL), moderate (105‒106 cfu/mL), and high (≥ 107 cfu/mL) peak density groups. The relationship between peak P. aeruginosa density and weaning from mechanical ventilation, risk factors for isolation of high peak density of P. aeruginosa, and antibiotic efficacy were investigated using multivariate and propensity score-matched analyses.

RESULTS: Four-hundred-and-sixty-one patients were enrolled. Patients with high peak density of P. aeruginosa had higher inflammation and developed more severe respiratory infections. High peak density of P. aeruginosa was independently associated with few ventilator-free days on day 28 (P < 0.01) and increased ICU mortality (P = 0.047). Risk factors for high peak density of P. aeruginosa were prolonged mechanical ventilation (odd ratio [OR] 3.07 95% confidence interval [CI] 1.35‒6.97), non-antipseudomonal cephalosporins (OR 2.17, 95% CI 1.35‒3.49), hyperglycemia (OR 2.01, 95% CI 1.26‒3.22) during ICU stay, and respiratory diseases (OR 1.9, 95% CI 1.12‒3.23). Isolation of commensal colonizer was associated with lower risks of high peak density of P. aeruginosa (OR 0.43, 95% CI 0.26‒0.73). Propensity score-matched analysis revealed that antibiotic therapy for patients with ventilator-associated tracheobronchitis improved weaning from mechanical ventilation only in the high peak P. aeruginosa group.

CONCLUSIONS: Patients with high peak density of P. aeruginosa had worse ventilator outcome and ICU mortality. In patients with ventilator-associated tracheobronchitis, antibiotic therapy was associated with favorable ventilator weaning only in the high peak P. aeruginosa density group, and bacterial density could be a good therapeutic indicator for ventilator-associated tracheobronchitis due to P. aeruginosa.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Migiyama Y, Sakata S, Iyama S, et al. Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics. Crit Care. 2021. PMID: 33573691. doi:10.1186/s13054-021-03488-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。